|
1
|
Stockenhuber K, Hegazy AN, West NR, Ilott
NE, Stockenhuber A, Bullers SJ, Thrnton EE, Arnold IC, Tucci A,
Waldmann H, et al: Foxp3+ T reg cells control
psoriasiform inflammation by restraining an IFN-I-driven
CD8+ T cell response. J Exp Med. 215:1987–1998. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parisi R, Iskandar IYK, Kontopantelis E,
Augustin M, Griffiths CEM and Ascroft DM; Global Psoriasis Atlas, :
National, regional, and worldwide epidemiology of psoriasis:
Systematic analysis and modelling study. BMJ. 369:m15902020.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Danielsen K, Olsen AO, Wilsgaard T and
Furberg AS: Is the prevalence of psoriasis increasing? A 30-year
follow-up of a population-based cohort. Br J Dermatol.
168:1303–1310. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim WB, Jerome D and Yeung J: Diagnosis
and management of psoriasis. Can Fam Physician. 63:278–285.
2017.PubMed/NCBI
|
|
5
|
Mrowietz U and Domm S: Systemic steroids
in the treatment of psoriasis: What is fact, what is fiction? J Eur
Acad Dermatol Venereol. 27:1022–1025. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ghasemian M, Owlia S and Owlia MB: Review
of anti-inflammatory herbal medicines. Adv Pharmacol Sci.
2016:91309792016.PubMed/NCBI
|
|
7
|
Zhao J, Di T, Wang Y, Wang Y, Liu X, Liang
D and Li P: Paeoniflorin inhibits imiquimod-induced psoriasis in
mice by regulating Th17 cell response and cytokine secretion. Eur J
Pharmacol. 772:131–143. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gallais Sérézal I, Hoffer E, Ignatov B,
Martini E, Zitti B, Ehrström M and Eidsmo L: A skewed pool of
resident T cells triggers psoriasis-associated tissue responses in
never-lesional skin from patients with psoriasis. J Allergy Clin
Immunol. 143:1444–1454. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li L, Huang L, Vergis AL, Ye H, Bajwa A,
Narayan V, Striter RM, Rosin DL and Okusa MD: IL-17 produced by
neutrophils regulates IFN-gamma-mediated neutrophil migration in
mouse kidney ischemia-reperfusion injury. J Clin Invest.
120:331–342. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hawkes JE, Yan BY, Chan TC and Krueger JG:
Discovery of the IL-23/IL-17 signaling pathway and the treatment of
psoriasis. J Immunol. 201:1605–1613. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee B, Bae EA, Trinh HT, Shin YW, Phuong
TT, Bae KH and Kim DH: Inhibitory effect of schizandrin on passive
cutaneous anaphylaxis reaction and scratching behaviors in mice.
Biol Pharm Bull. 30:1153–1156. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim H, Ahn YT, Kim YS, Cho SI and An WG:
Antiasthmatic effects of schizandrae fructus extract in mice with
asthma. Pharmacogn Mag. 10 (Suppl 1):S80–S85. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Szopa A, Ekiert R and Ekiert H: Current
knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese
magnolia vine) as a medicinal plant species: A review on the
bioactive components, pharmacological properties, analytical and
biotechnological studies. Phytochem Rev. 16:195–218. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chae HS, Kang OH, Oh YC, Choi JG, Keum JH,
Kim SB, Kim YS, Mun SH, Shin DW, Han SH and Kwon DY: Gomisin N has
anti-allergic effect and inhibits inflammatory cytokine expression
in mouse bone marrow-derived mast cells. Immunopharmacol
Immunotoxicol. 33:709–713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Opletal L, Sovová H and Bártlová M:
Dibenzo[a,c]cyclooctadiene lignans of the genus Schisandra:
Importance, isolation and determination. J Chromatogr B Analyt
Technol Biomed Life Sci. 812:357–371. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Korkina L, Kostyuk V, De Luca C and
Pastore S: Plant phenylpropanoids as emerging anti-inflammatory
agents. Mini Rev Med Chem. 11:823–835. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dhakal H, Lee S, Kim EN, Choi JK, Kim MJ,
Kang J, Choi YA, Baek MC, Lee B, Lee HS, et al: Gomisin M2 inhibits
mast cell-mediated allergic inflammation via attenuation of
FcεRI-mediated Lyn and Fyn activation and intracellular calcium
levels. Front Pharmacol. 10:8692019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen M, Kilgore N, Lee KH and Chen DF:
Rubrisandrins A and B, lignans and related anti-HIV compounds from
Schisandra rubriflora. J Nat Prod. 69:1697–1701. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hou X, Deng J, Zhang Q, Wang D, Kennedy D,
Quinn RJ and Feng Y: Cytotoxic ethnic Yao medicine Baizuan, leaves
of Schisandra viridis A. C. Smith. J Ethnopharmacol.
194:146–152. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li F, Zhang T, Sun H, Gu H, Wang H, Su X,
Li C, Li B, Chen R and Kang J: A new nortriterpenoid, a
sesquiterpene and hepatoprotective lignans isolated from the fruit
of Schisandra chinensis. Molecules. 22:19312017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Public Health Service, . Public health
service policy on humane care and use of laboratory animals, US
Department of Health and Human Services. NIH publication No.
15-80137-25. 2015.
|
|
22
|
Uva L, Miguel D, Pinheiro C, Antunes J,
Cruz D, Ferreira J and Filipe P: Mechanisms of action of topical
corticosteroids in psoriasis. Int J Endocrinol. 2012:5610182012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Araki-Sasaki K, Katsuta O, Mano H, Nagano
T and Nakamura M: The effects of oral and topical corticosteroid in
rabbit corneas. BMC Ophthalmol. 16:1602016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Samtani MN and Jusko WJ: Comparison of
dexamethasone pharmacokinetics in female rats after intravenous and
intramuscular administration. Biopharm Drug Dispos. 26:85–91. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeong NH, Lee S, Choi JK, Choi YA, Kim MJ,
Lee HS, Shin TY, Jang YH, Song KS and Kim SH: Polyozellin
alleviates atopic dermatitis-like inflammatory and pruritic
responses in activated keratinocytes and mast cells. Biomed
Pharmacother. 122:1097432020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Q, Liu W, Gao S, Mao Y and Xin Y:
Application of imiquimod-induced murine psoriasis model in
evaluating interleukin-17A antagonist. BMC Immunol. 22:112021.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lim JS, Kim JY, Lee S, Choi JK, Kim EN,
Choi YA, Jang YH, Jeong GS and Kim SH: Bakuchicin attenuates atopic
skin inflammation. Biomed Pharmacother. 129:1104662020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lowes MA, Suárez-Fariñas M and Krueger JG:
Immunology of psoriasis. Annu Rev Immunol. 32:227–255. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Feldman SR and Krueger GG: Psoriasis
assessment tools in clinical trials. Ann Rheum Dis. 64 (Suppl
2):ii65–ii73. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chiang CC, Cheng WJ, Korinek M, Lin CY and
Hwang TL: Neutrophils in psoriasis. Front Immunol. 10:23762019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Furiati SC, Catarino JS, Silva MV, Silva
RF, Estevam RB, Teodoro RB, Pereira SL, Ataide M, Rodrigues V Jr
and Rodrigues DBR: Th1, Th17, and Treg responses are differently
modulated by TNF-α inhibitors and methotrexate in psoriasis
patients. Sci Rep. 9:75262019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bhattacharjee O, Ayyangar U, Kurbet AS,
Ashok D and Raghavan S: Unraveling the ECM-immune cell crosstalk in
skin diseases. Front Cell Dev Biol. 7:682019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schonmann Y, Ashcroft DM, Iskandar IYK,
Parisi R, Sde-Or S, Comaneshter D, Batat E, Shani M, Vinker S,
Griffiths CEM and Cohen AD: Incidence and prevalence of psoriasis
in Israel between 2011 and 2017. J Eur Acad Dermatol Venereol.
33:2075–2081. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kamiya K, Kishimoto M, Sugai J, Komine M
and Ohtsuki M: Risk factors for the development of psoriasis. Int J
Mol Sci. 20:43472019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Meng S, Lin Z, Wang Y, Wang Z, Li P and
Zheng Y: Psoriasis therapy by Chinese medicine and modern agents.
Chin Med. 13:162018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Atanasov AG, Zotchev SB, Dirsch VM;
International Natural Product Sciences Taskforce, ; Supuran CT:
Natural products in drug discovery: Advances and opportunities. Nat
Rev Drug Discov. 20:200–216. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim EJ, Jang M, Lee MJ, Choi JH, Lee SJ,
Kim SK, Jang DS and Cho IH: Schisandra chinensis stem
ameliorates 3-nitropropionic acid-induced striatal toxicity via
activation of the Nrf2 pathway and inhibition of the MAPKs and
NF-κB pathways. Front Pharmacol. 8:6732017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Panossian A and Wikman G: Pharmacology of
Schisandra chinensis Bail.: An overview of Russian research and
uses in medicine. J Ethnopharmacol. 118:183–212. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Szopa A, Barnaś M and Ekiert H:
Phytochemical studies and biological activity of three Chinese
Schisandra species (Schisandra sphenanthera, Schisandra
henryi and Schisandra rubriflora): Current findings and
future applications. Phytochem Rev. 18:109–128. 2019. View Article : Google Scholar
|
|
41
|
Yang Y, Hao E, Pan X, Tan D, Du Z, Xie J,
Hou X, Deng J and Wei K: Gomisin M2 from Baizuan suppresses breast
cancer stem cell proliferation in a zebrafish xenograft model.
Aging (Albany NY). 11:8347–8361. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tokuyama M and Mabuchi T: New treatment
addressing the pathogenesis of psoriasis. Int J Mol Sci.
21:74882020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Siiskonen H and Harvima I: Mast cells and
sensory nerves contribute to neurogenic inflammation and pruritus
in chronic skin inflammation. Front Cell Neurosci. 13:4222019.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Diani M, Altomare G and Reali E: T helper
cell subsets in clinical manifestations of psoriasis. J Immunol
Res. 2016:76920242016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ogawa E, Sato Y, Minagawa A and Okuyama R:
Pathogenesis of psoriasis and development of treatment. J Dermatol.
45:264–272. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Odobasic D, Kitching AR and Holdsworth SR:
Neutrophil-mediated regulation of innate and adaptive immunity: The
role of myeloperoxidase. J Immunol Res. 2016:23498172016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dilek N, Dilek AR, Taşkın Y, Erkinüresin
T, Yalçın Ö and Saral Y: Contribution of myeloperoxidase and
inducible nitric oxide synthase to pathogenesis of psoriasis.
Postepy Dermatol Alergol. 33:435–439. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kyriakou A, Patsatsi A, Vyzantiadis TA and
Sotiriadis D: Serum levels of TNF-α, IL-12/23p40, and IL-17 in
plaque psoriasis and their correlation with disease severity. J
Immunol Res. 2014:4675412014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wallen-Russell C: Is there a relationship
between transepidermal water loss and microbial biodiversity on the
skin? Cosmetics. 6:182019. View Article : Google Scholar
|
|
50
|
Zhou F, Zhu Z, Gao J, Yang C, Wen L, Liu
L, Zuo X, Zheng X, Shi Y, Zhu C, et al: NFKB1 mediates Th1/Th17
activation in the pathogenesis of psoriasis. Cell Immunol.
331:16–21. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Gröne A: Keratinocytes and cytokines. Vet
Immunol Immunopathol. 88:1–12. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang L, Zhao Y, Liu Y, Akiyama K, Chen C,
Qu C, Jin Y and Shi S: IFN-γ and TNF-α synergistically induce
mesenchymal stem cell impairment and tumorigenesis via NFκB
signaling. Stem Cells. 31:1383–1395. 2013. View Article : Google Scholar : PubMed/NCBI
|
